Optimizing efficacy of mucosal vaccines

Area of Science:

• Immunology
• Vaccinology
• Biotechnology

Background:

• The mucosal immune system presents significant challenges for vaccine administration due to its complex structure and immune cell interactions.
• Existing experimental methodologies have limitations, necessitating tailored strategies for different mucosal surfaces.

Purpose of the Study:

• To review current strategies for improving the efficacy of vaccines delivered via mucosal routes.
• To examine the role of adjuvants, delivery systems, and mucoadhesives in enhancing mucosal vaccine performance.

Main Methods:

• Literature review focusing on mucosal vaccine delivery routes (oral/intestinal, nasal/respiratory, female genital tract).
• Analysis of coadministration strategies involving immune-stimulatory molecules, adjuvants, delivery systems, and mucoadhesives.

Main Results:

• Coadministration of specific molecules and systems can overcome hurdles in mucosal vaccine delivery.
• Different strategies are required for optimizing efficacy across various mucosal surfaces.

Conclusions:

• Next-generation mucosal vaccines require improved efficacy, safety, and user-friendly administration methods.
• Technological advancements and reduced manufacturing costs are crucial for the widespread adoption of mucosal vaccines.